Found: 15
Select item for more details and to access through your institution.
The Pharmacokinetics of Daclatasvir and Asunaprevir Administered in Combination in Studies in Healthy Subjects and Patients Infected with Hepatitis C Virus.
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 9, p. 661, doi. 10.1007/s40261-014-0219-9
- By:
- Publication type:
- Article
A Review of Daclatasvir Drug-Drug Interactions.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Asunaprevir: An HCV Protease Inhibitor With Preferential Liver Distribution.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 2, p. 195, doi. 10.1002/cpdd.315
- By:
- Publication type:
- Article
Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 2, p. 465, doi. 10.1093/jac/dkr490
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis of Asunaprevir in Subjects with Hepatitis C Virus Infection.
- Published in:
- Infectious Diseases & Therapy, 2018, v. 7, n. 2, p. 261, doi. 10.1007/s40121-018-0197-y
- By:
- Publication type:
- Article
Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects.
- Published in:
- Drugs in R&D, 2018, v. 18, n. 1, p. 55, doi. 10.1007/s40268-017-0222-8
- By:
- Publication type:
- Article
Daclatasvir: A Review of Preclinical and Clinical Pharmacokinetics.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Population Pharmacokinetic Analysis of Daclatasvir in Subjects with Chronic Hepatitis C Virus Infection.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Asunaprevir: A Review of Preclinical and Clinical Pharmacokinetics and Drug-Drug Interactions.
- Published in:
- 2015
- By:
- Publication type:
- journal article
From Bench to Humans: Formulation Development of a Poorly Water Soluble Drug to Mitigate Food Effect.
- Published in:
- AAPS PharmSciTech, 2014, v. 15, n. 2, p. 407, doi. 10.1208/s12249-013-0069-4
- By:
- Publication type:
- Article
No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients.
- Published in:
- Liver International, 2016, v. 36, n. 2, p. 189, doi. 10.1111/liv.12964
- By:
- Publication type:
- Article
Effect of Low-Dose Omeprazole (20 mg Daily) on the Pharmacokinetics of Multiple-Dose Atazanavir With Ritonavir in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 3, p. 368, doi. 10.1177/0091270010367651
- By:
- Publication type:
- Article
Phase I Study of the Effect of Gastric Acid pH Modulators on the Bioavailability of Oral Dasatinib in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 6, p. 700, doi. 10.1177/0091270009333854
- By:
- Publication type:
- Article
Phase I Study of the Effect of Gastric Acid pH Modulators on the Bioavailability of Oral Dasatinib in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 6, p. 700, doi. 10.1177/0091270009333854
- By:
- Publication type:
- Article